Preterm birth, neonatal therapies and the risk of childhood cancer
Laura K. Seppälä(University of Helsinki), Laura Madanat‐Harjuoja(Finnish Cancer Registry), Maarit K. Leinonen(University of Helsinki), Kim Vettenranta(Universität Hamburg), Viena Tommiska(Helsinki Children's Hospital)
Cited by 36
Related Papers
Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study
|The Lancet Oncology|2017|510
Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study
|Journal of Clinical Oncology|2020|333
Age-Specific Evaluation of Primary Human Papillomavirus Screening vs Conventional Cytology in a Randomized Setting
|JNCI Journal of the National Cancer Institute|2009|265
Association of Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability
|JAMA Neurology|2022|265
Clinical Outcome of Children With Newly Diagnosed Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia Treated Between 1995 and 2005
|Journal of Clinical Oncology|2010|247